ABSTRACT
COVID-19 is a novel respiratory disease first identified in Wuhan, China, that is caused by the novel coronavirus, SARS-CoV-2. To better understand the dynamics of the COVID-19 pandemic in the Philippines, we have used real-time mobility data to modify the DELPHI Epidemiological Model recently developed at M.I.T., and to simulate the pandemic in Metro Manila. We have chosen to focus on the National Capital Region, not only because it is the nation’s demographic heart where over a tenth of the country’s population live, but also because it has been the epidemiological epicenter of the Philippine pandemic. Our UST CoV-2 model suggests that the government-imposed enhanced community quarantine (ECQ) has successfully limited the spread of the pandemic. It is clear that the initial wave of the pandemic is flattening, though suppression of viral spread has been delayed by the local pandemics in the City of Manila and Quezon City. Our data also reveals that replacing the ECQ with a General Community Quarantine (GCQ) will increase the forecasted number of deaths in the nation’s capital unless rigorous tracing and testing can be implemented to prevent a second wave of the pandemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received for the work described in this manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This epidemiological study did not require IRB approval.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
This epidemiological study used publicly available data sets provided by the Department of Health of the Philippines at https://www.doh.gov.ph/covid19tracker
